Molecular and genetic testing has become a game-changer in brain tumor care—shaping diagnosis, guiding treatments and opening ...
News-Medical.Net on MSN
Advancements in molecular and genetic testing transform brain tumor care
Molecular and genetic testing has become a game-changer in brain tumour care - shaping diagnosis, guiding treatments and opening doors to new therapies.
Free radicals generated at a specific site in non-neuronal brain cells called astrocytes may promote dementia, according to a ...
It sounds like something from a horror movie: A disease that eats through bone, dissolving the fused plates of the skull like bubbling acid. But a type of brain cancer called glioblastoma actually ...
Weill Cornell researchers uncovered how free radicals from astrocyte mitochondria can fuel dementia. Using new compounds that ...
A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, scientists preserved cognition in mice without dulling the cancer-killing ...
Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, according to a new study that comes as the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming ...
For Stephen Greene, an attorney and father of two, the first symptoms of a brain tumor were subtle — and not obviously linked. He first noticed a tingling on the right side of his tongue and a slight ...
Chemotherapy, anti-cancer drugs that stop the growth of tumor cells, encompasses a wide variety of different agents. Some chemotherapeutic agents work by directly killing cancer cells, while others ...
Laura Standen receives funding from Barts Charity. Suzanne Scott receives funding for research from Barts Charity, National Institute of Health and Care Research, Cancer Research UK, Google LLC, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results